{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:25:16Z","timestamp":1776461116806,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2011,4,30]],"date-time":"2011-04-30T00:00:00Z","timestamp":1304121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s10072-011-0538-z","type":"journal-article","created":{"date-parts":[[2011,4,29]],"date-time":"2011-04-29T18:55:21Z","timestamp":1304103321000},"page":"135-139","source":"Crossref","is-referenced-by-count":9,"title":["Oral contraceptives in migraine therapy"],"prefix":"10.1007","volume":"32","author":[{"given":"Gianni","family":"Allais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Castagnoli Gabellari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"De Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ornella","family":"Mana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,30]]},"reference":[{"key":"538_CR1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1067\/mob.2001.117416","volume":"185","author":"RT Burkman","year":"2001","unstructured":"Burkman RT, Collins JA, Shulman LP, Williams JK (2001) Current perspectives on oral contraceptive use. Am J Obstet Gynecol 185:S4\u2013S12","journal-title":"Am J Obstet Gynecol"},{"key":"538_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1468-2982.2000.00036.x","volume":"20","author":"EA MacGregor","year":"2000","unstructured":"MacGregor EA, de Ligni\u00e8res B (2000) The place of combined oral contraceptives in contraception. Cephalalgia 20:157\u2013163","journal-title":"Cephalalgia"},{"key":"538_CR3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajog.2004.12.089","volume":"193","author":"EW Loder","year":"2005","unstructured":"Loder EW, Buse DC, Golub JR (2005) Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol 193:636\u2013649","journal-title":"Am J Obstet Gynecol"},{"key":"538_CR4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1526-4610.2000.00027.x","volume":"40","author":"L Mueller","year":"2000","unstructured":"Mueller L (2000) Predictability of exogenous hormone effect in subgroups of migraineurs. Headache 40:189\u2013193","journal-title":"Headache"},{"key":"538_CR5","first-page":"126","volume":"8","author":"EA MacGregor","year":"1997","unstructured":"MacGregor EA, Igarashi H, Wilkinson M (1997) Headaches and hormones: subjective versus objective assessment. Headache Q 8:126\u2013136","journal-title":"Headache Q"},{"key":"538_CR6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1468-2982.1995.015002140.x","volume":"15","author":"LM Cupini","year":"1995","unstructured":"Cupini LM, Matteis M, Troisi E, Calabresi P, Bernardi G, Silvestrini M (1995) Sex-hormone related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 15:140\u2013144","journal-title":"Cephalalgia"},{"key":"538_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1526-4610.1993.hed3307385.x","volume":"33","author":"F Granella","year":"1993","unstructured":"Granella F, Sances G, Zanferrari C, Costa A, Martignoni GC (1993) Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache 33:385\u2013389","journal-title":"Headache"},{"key":"538_CR8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1468-2982.2000.00038.x","volume":"20","author":"H Massiou","year":"2000","unstructured":"Massiou H, MacGregor EA (2000) Evolution and treatment of migraine with oral contraceptives. Cephalalgi 20:170\u2013174","journal-title":"Cephalalgi"},{"issue":"1","key":"538_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1783\/147118902101195974","volume":"28","author":"EA MacGregor","year":"2002","unstructured":"MacGregor EA, Hackshaw A (2002) Prevention of migraine in the pill-free week of combined oral contraceptives using natural oestrogen supplements. J Fam Plann Reprod Health Care 28(1):27\u201331","journal-title":"J Fam Plann Reprod Health Care"},{"key":"538_CR10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0029-7844(99)00524-4","volume":"95","author":"PJ Sulak","year":"2000","unstructured":"Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ (2000) Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95:261\u2013266","journal-title":"Obstet Gynecol"},{"key":"538_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","volume":"47","author":"P Sulak","year":"2007","unstructured":"Sulak P, Willis S, Kuehl T, Coffee A, Clark J (2007) Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 47:27\u201337","journal-title":"Headache"},{"issue":"Suppl 1","key":"538_CR12","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1007\/s10072-008-0921-6","volume":"29","author":"G Allais","year":"2008","unstructured":"Allais G, Bussone G, Airola G, Borgogno P, Castagnoli Gabellari I, de Lorenzo C, Pavia E, Benedetto C (2008) Oral contraceptive-induced menstrual migraine. Clinical aspects and response to frovatriptan. Neurol Sci 29(Suppl 1):S186\u2013S190","journal-title":"Neurol Sci"},{"key":"538_CR13","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1212\/01.wnl.0000233888.18228.19","volume":"67","author":"EA MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67:2154\u20132158","journal-title":"Neurology"},{"key":"538_CR14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1526-4610.1992.hed3206312.x","volume":"32","author":"SD Silberstein","year":"1992","unstructured":"Silberstein SD (1992) Menstrual migraine. Headache 32:312\u2013313","journal-title":"Headache"},{"key":"538_CR15","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jama.295.15.1824","volume":"295","author":"JL Brandes","year":"2006","unstructured":"Brandes JL (2006) The influence of estrogen on migraine: a systematic review. JAMA 295:1824\u20131830","journal-title":"JAMA"},{"issue":"Suppl.1","key":"538_CR16","first-page":"1","volume":"24","author":"Headache Classification Committee of the International Headache Society","year":"2004","unstructured":"Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24(Suppl.1):1\u2013160","journal-title":"Cephalalgia"},{"key":"538_CR17","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1067\/mob.2002.122988","volume":"186","author":"PJ Sulak","year":"2002","unstructured":"Sulak PJ, Kuehl TJ, Ortiz M, Shull BL (2002) Acceptance of altering the standard 21-day\/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 186:1142\u20131149","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"538_CR18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bpobgyn.2007.08.004","volume":"22","author":"PJ Sulak","year":"2008","unstructured":"Sulak PJ (2008) Continuous oral contraception: changing times. Best Pract Res Clin Obstet Gynaecol 22(2):355\u2013374","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"538_CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2008.02.019","volume":"78","author":"D Klipping","year":"2008","unstructured":"Klipping D, Duijkers I, Trummer D, Marr J (2008) Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24\/4 regimen. Contraception 78(1):16\u201325","journal-title":"Contraception"},{"issue":"1","key":"538_CR20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0015-0282(99)00205-8","volume":"72","author":"H Sullivan","year":"1999","unstructured":"Sullivan H, Furniss H, Spona J, Elstein M (1999) Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60\u00a0\u03bcg) and ethinyl estradiol (15\u00a0\u03bcg) on ovarian activity. Fertil Steril 72(1):115\u2013120","journal-title":"Fertil Steril"},{"key":"538_CR21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2006.08.004","volume":"75","author":"ST Nakajima","year":"2007","unstructured":"Nakajima ST, Archer DF, Ellman H (2007) Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1\u00a0mg\/ethinyl estradiol 20\u00a0\u03bcg (Loestrin\u00ae 24 Fe). Contraception 75:16\u201322","journal-title":"Contraception"},{"key":"538_CR22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2008.04.001","volume":"78","author":"A Poindexter","year":"2008","unstructured":"Poindexter A, Reape KZ, Hait H (2008) Efficacy and safety of a 28-day oral contraceptive with 7\u00a0days of low dose estrogen in place of placebo. Contraception 78:113\u2013119","journal-title":"Contraception"},{"key":"538_CR23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/14.4.982","volume":"14","author":"CF Rice","year":"1999","unstructured":"Rice CF, Killick SR, Dieben T, Coelingh Bennink H (1999) A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily. Hum Reprod 14:982\u2013985","journal-title":"Hum Reprod"},{"key":"538_CR24","doi-asserted-by":"crossref","unstructured":"Grimes DA, Lopez LM, O\u2019Brien PA, Raymond EG (2010) Progestin-only pills for contraception. Cochrane Database Syst Rev (1):CD007541","DOI":"10.1002\/14651858.CD007541.pub2"},{"key":"538_CR25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/13625180701536771","volume":"12","author":"HJ Ahrendt","year":"2007","unstructured":"Ahrendt HJ, Karckt U, Pichl T, Mueller T, Ernst U (2007) The effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: results form two studies on oestrogen-related symptoms and dysmenorrhea. Eur J Contracept Reprod Health Care 12:354\u2013361","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"538_CR26","first-page":"2","volume":"48","author":"HJ Ahrendt","year":"2007","unstructured":"Ahrendt HJ, Kleinschmidt S, Kropf S et al (2007) Pr\u00e4ventive Wirkung hormoneller Kontrazeptiva im Langzyklus bei menstrueller Migr\u00e4ne. Frauenarzt 48:2\u20137","journal-title":"Frauenarzt"},{"key":"538_CR27","unstructured":"World Health Organization (2004) Family and Reproductive Health Programme. Improving access to quality care in family planning: medical eligibility criteria for contraceptive use, 3rd edn. World Health Organization Geneva, Switzerland"},{"key":"538_CR28","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","volume":"107","author":"ACOG Committee on Practice Bulletins-Gynecology","year":"2006","unstructured":"ACOG Committee on Practice Bulletins-Gynecology (2006) ACOG practice bulletin. No73: use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 107:1453\u20131472","journal-title":"Obstet Gynecol"},{"key":"538_CR29","unstructured":"Faculty of Sexual and Reproductive Health Care (2009) UK medical eligibility criteria for contraceptive use (UKMEC 2009). Published by the Faculty of Sexual and Reproductive Health Care\u2014Royal College of Obstetricians and Gynaecologists. Available at http:\/\/ffprhc.org.uk\/admin\/uploads\/UKMEC209.pdf"},{"issue":"3","key":"538_CR30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2010.07.024","volume":"83","author":"EW Nappi","year":"2011","unstructured":"Nappi EW, Sances G, Allais G, Terreno E, Benedetto C, Vaccaro V, Polatti F, Facchinetti F (2011) Effects of an estrogen-free, desogestrel-containing oral contraceptive in women with migraine with aura: a prospective diary-based pilot study. Contraception 83(3):223\u2013228","journal-title":"Contraception"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-011-0538-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-011-0538-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-011-0538-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T12:13:32Z","timestamp":1712405612000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-011-0538-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,30]]},"references-count":30,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1007\/s10072-011-0538-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,30]]}}}